Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Effectiveness of the recombinant zoster vaccine in adult patients with multiple sclerosis: A claims-based retrospective cohort study in the United States.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 13, 2026
Potential infliximab-induced Kounis syndrome in a patient with metastatic melanoma.
Journal: Allergologie select
Published: September 25, 2025
Tumor sialylation regulates G-CSF stability and promotes neutrophil-mediated immunosuppression in breast cancer.
Journal: Nature communications
Published: August 28, 2025
Effectiveness and safety of the recombinant zoster vaccine in adult patients with systemic lupus erythematosus: a claims-based retrospective cohort study in the USA.
Journal: RMD open
Published: April 25, 2025
Correction: Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.
Journal: Acta neuropathologica communications
Published: September 18, 2024
Pseudorabies virus hijacks DDX3X, initiating an addictive "mad itch" and immune suppression, to facilitate viral spread.
Journal: bioRxiv : the preprint server for biology
Published: May 22, 2023
Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs.
Journal: PLoS biology
Published: November 16, 2022
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial.
Journal: Critical care (London, England)
Published: September 12, 2022
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.
Journal: American journal of respiratory and critical care medicine
Published: August 04, 2022
Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial.
Journal: The Journal of antimicrobial chemotherapy
Published: January 26, 2022
Last Updated: 09/26/2026